Title: Correlation of blood glucose with lactate dehydrogenase in diabetic and non diabetic patients with viral infection
Author: Santosh Saxena
DOI: https://dx.doi.org/10.18535/jmscr/v12i04.02
Abstract
Introduction
The patients having diabetes and are also infected by viruses are more likely to develop the morbidity symptoms in contrast to the non-diabetic virus affected patients. Diabetes mellitus in viral affected patients stimulates the susceptible complicated side effects with side by side lowering of the immunity of the body and the immune system. (5) Diabetes mellitus is a challenging disease in the way of virus affected population of patients.
This disease has the ability to interfere with host and viral activities and interactions along with host and immunity via many principles and mechanisms which would result in quite poor results and outcomes. Patients of diabetes mellitus along with complications like high blood pressure and grade two obesity (BMI ≥ 40 kg/m2) might get high symptoms and are at a increasing risk for side effects and even death. (6)
Aims and Objectives
To study the correlation between LDH and serum glucose in diabetic and non diabetic patients with viral infection
References
- Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol [Internet]. 2020; 16(6):297–8. Available from: http://dx.doi.org/10.1038/s41574-020-0353-9
- Choi JY, Smith DM. SARS-CoV-2 variants of concern. Yonsei Med J [Internet].2021;62(11):961–8.Availablefrom: http://dx.doi.org/10.3349/ymj.2021.62.11.961
- Deshmukh V, Shaikh AK, Habbu P. Type 2 Diabetes and COVID-19 Related Mortality in Solapur: A Whole Population Study. Int J Pharm Sci Rev Res. 2021;67(2):83–6.
- Erba Diagnostics Limited,H-360 Hemotology analyser, Revision 0 SW version 1.0, Erba Diagnostics Limited. Vol. 4. Block K, Central Park, Leopardstown, Dublin; Ireland;
- Henry RJ, Chiamori N, Golub OJ, Berkman S. Revised spectrophotometric methods for the determination of glutamic- oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol [Internet]. 1960;34(4_ts):381– Available from: http://dx.doi.org/10.1093/ajcp/34.4_ts.381
- Lai A C-C, Shihb T-P, Koc W-C, Tang H-J. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
- Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents [Internet].2020;55(5):105951.Availablefrom: http://dx.doi.org/10.1016/j.ijantimicag.2020.105951
- Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol [Internet]. 2021;17(1):11–30. Available from: http://dx.doi.org/10.1038/s41574-020-00435-4
- Lum G, Gambino SR. A comparison of serum versus heparinized plasma for routine chemistry tests. Am J Clin Pathol [Internet]. 1974;61(1):108–13. Available from: http://dx.doi.org/10.1093/ajcp/61.1.108
- Sarkar S, Das D, Borsingh Wann S, Kalita J, Manna P. Is diabetes mellitus a wrongdoer to COVID-19 severity? Diabetes Res Clin Pract [Internet]. 2021;178(108936):108936. Available from: http://dx.doi.org/10.1016/j.diabres.2021.108936
- Yina Y, Rohli KE, Shenb P, Lub H. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review. 2021;899–909.
- Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med [Internet]. 2022;20(1):444. Available from: http://dx.doi.org/10.1186/s12916-022-02656-y